Immune disease comorbidities

ASTHMA_IMMUNECOMORB

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
ASTHMA_IMMUNECOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 34936 21875 13061
Unadjusted prevalence (%) 9.82 11.03 8.30
Mean age at first event (years) 49.27 47.65 51.97

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.88 [1.64, 2.15] 4.7e-20 3996
15 years 0.01 1.21 [1.08, 1.35] 7.4e-4 1652
5 years 0.00 2.32 [2.11, 2.56] 4.4e-64 1010
1 year 0.00 6.21 [5.46, 7.05] <1e-100 534

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ASTHMA_IMMUNECOMORB – Immune disease comorbidities
GWS hits:

Survival analyses between endpoints

Plot

before Immune disease comorbidities
after Immune disease comorbidities

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Immune disease comorbidities